Land: Storbritannia
Språk: engelsk
Kilde: MHRA (Medicines & Healthcare Products Regulatory Agency)
Pericyazine
Pharma-z Ltd
N05AC01
Pericyazine
10mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 04020100
PACKAGE LEAFLET: INFORMATION FOR THE USER NEULACTIL ® 10MG TABLETS (pericyazine) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU ARE GIVEN THIS MEDICINE Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. The name of your medicine is Neulactil 10mg Tablets but will be referred to as Neulactil throughout this leaflet. IN THIS LEAFLET: 1. What Neulactil is and what it is used for 2. Before you take Neulactil 3. How to take Neulactil 4. Possible side effects 5. How to store Neulactil 6. Further Information Neulactil belongs to a group of medicines called ‘phenothiazines’. It works by blocking the effect of a chemical in the brain. It can be used for: Schizophrenia The short term treatment of anxiety, agitation and violent or dangerously impulsive behaviour when used with other medicines DO NOT TAKE THIS MEDICINE AND TELL YOUR DOCTOR IF: You are allergic (hypersensitive) to pericyazine or any of the other ingredients in this medicine (listed in Section 6) Signs of an allergic reaction include: a rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue You are pregnant, might become pregnant or think you may be pregnant (see Section below: ‘Pregnancy and breast-feeding’) Do not take this medicine if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking Neulactil. TAKE SPECIAL CARE WITH NEULACTIL CHECK WITH YOUR DOCTOR OR PHARMACIST BEFORE YOU TAKE THIS MEDICINE IF: ▲ You have heart problems or a family history of heart problems ▲ You have ever had a stroke ▲ You have liver or kidney problems ▲ You have thyroid problems ▲ You have Parkinson’s disease ▲ You h read_full_document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Pericyazine 10mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Pericyazine 10mg 3 PHARMACEUTICAL FORM Pericyazine 10mg Tablets: Circular, very pale lime-yellow tablet, with one face impressed ‘S172’ and a break-line on reverse. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS a) In adults with schizophrenia or other psychoses, for the treatment of symptoms or prevention of relapse. b) In anxiety, psychomotor agitation, violent or dangerously impulsive behaviour. Pericyazine is used as an adjunct to the short-term management of these conditions. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _Route of administration_: oral . Dosage requirement varies with the individual and the severity of the condition being treated. Initial dosage should be low with progressive increases until the desired response is obtained, after which dosage should be adjusted to maintain control of the symptoms. _ Severe conditions _ _Indication (a) _ _ _ Adults:_ _Initially 75 mg per day in divided doses. Dosage should be increased by 25 mg per day at weekly intervals until the optimum effect is achieved. Maintenance therapy would not normally be expected to exceed 300 mg per day. Elderly: _ _Initially 15-30 mg per day in divided doses. If this is well tolerated the dosage may be increased if necessary for optimum control of behaviour. _Mild or moderate conditions _ _ _ _Indication (b) _ _ _ Adults: Initially 15-30 mg daily, divided into two portions with a larger dose being given in the evening. Elderly: 5-10 mg per day is suggested as a starting dose. It may be divided so that a larger portion is given in the evening. Half or quarter the normal adult dose may be sufficient for maintenance therapy. Pericyazine tablets are not recommended for children. 4.3 CONTRAINDICATIONS See use in pregnancy below. Known hypersensitivity to pericyazine or to any of the other ingredients. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Neuroleptics should be avoided in patients with li read_full_document